|Former: Atención Farmacéutica|
|Journal edited by Rasgo Editorial since 1983|
Maruxa Hernández Corredoira
EDITOR IN CHIEF
Manuela Velázquez Prieto
Tomás Casasín Edo
María B. Badía Tahull
Lluís Campins Bernadas
Juan Carlos Juárez Giménez
Carles Quiñones Ribas
Volume 23 - Issue 1, January-March 2021
DIRECT ECONOMIC IMPACT OF PHARMACIST’S INTERVENTIONS IN EMERGENCY DEPARTMENT: A PROSPECTIVE STUDY IN A LOWERMIDDLE INCOME COUNTRY
MRANI ALAOUI AMAL, MADANI NAOUFEL, BELAYACHI JIHANE, TAOUFIK JAMAL, ABOUQAL REDOUANE, CHAIBI AICHA
Context: Clinical pharmacy services employ the pharmacotherapeutic expertise to ensure optimal patient outcomes and can improve the quality, safety and efficiency of care.
Objective: The aim of the study is to measure the direct economic impact of pharmaceutical interventions issued during the analysis of prescriptions in a Moroccan medical emergency department.
Method: The prospective study was conducted over a period of eight months in the Medical Emergency Department of Ibn sina University Hospital in Rabat, Morocco.
The direct drug cost-savings were assessed from the point of view of the hospital center.
Pharmaceutical Interventions (PI) with a potential direct economic impact were selected. The total direct drug cost-savings was calculated according to the hypothesis of a single day impacted. The ratio of cost-savings to induced costs was calculated as well as the return on investment.
Results: Of the 304 pharmaceutical interventions, 113 were selected for economic impact assessment. Direct drug cost-savings during the study period was determined to be 926.51 USD in a single day impacted and a return on investment of 822.4% was found. Cost savings/induced costs ratio was 9.22. Dose adjustment saved 396.93 USD and treatment discontinuation saved 350.42 USD per one day impacted.
Conclusion: A beneficial effect of having a clinical pharmacist involved in patient care in the emergency department was observed in our study, based on the number of accepted pharmacist interventions and the potential cost avoidance.
COSTS AND COST ANALYSIS – CLINICAL PHARMACY – EMERGENCY MEDICINE – MEDICATION ERROR – PHARMACEUTICAL INTERVENTION – PRESCRIPT ION ANALYSIS